Dispersive extracorporeal shock wave therapy the value of it in ischemic stroke patients with dysphagia
Objective To explore the value of rESWT in ischemic stroke patients with Dysphagia.Methods A total of 108 patients with ischemic stroke complicated with dysphagia who were admitted to the Department of Rehabilitation Medicine,Shuguang Hospital Affiliated to the University of Traditional Chinese Medicine from January 2022 to January 2023 were selected and randomly divided into an observation group and a control group,with 54 cases in each group.The control group received swallowing rehabilitation training,while the observation group received rESWT intervention treatment on the basis of the control group.The Watian Swallowing Test(WST)was used to evaluate the intervention effect.The Swallowing Severity Scale(SSA),Functional Oral Intake Scale(FOIS),and Penetration-Aspiration Scale(PAS)were used to evaluate the swallowing function.The quality of life was assessed with the dysphagia-specific quality of life inventory(SWAL-QOL)and the general quality of life inventory(CQOL-74),and the adverse reactions and complications were recorded.Results After intervention,the overall level of WST grading changes in both groups of patients was better than before intervention in the same group,and the observation group was better than the control group(Z=9.480,P<0.05).After intervention,the SSA and PAS scores of the two groups of patients were lower than those of the same group before intervention,and the observation group was lower than the control group(t=7.551,8.971,P<0.05).The FOIS score was higher than before intervention in the same group,and the observation group was higher than the control group(t=3.828,P<0.05).After intervention,the CQOL-74 scores and SWAL-QOL scores of both groups of patients were higher than those of the same group before intervention,and the observation group was higher than the control group(t=10.769,21.291,11.538,9.217,P<0.05).The incidence of complications in the observation group was significantly lower than that in the control group(χ2 = 4.860,P= 0.027).Conclusion rESWT can effectively promote the early recovery of swallowing function in ischemic stroke patients with dysphagia,improve their quality of life,and has good safety,which has certain clinical application value.
NETL
NSTL
万方数据
